Nonsense-mediated decay and the molecular pathogenesis of mutations in SALL1 and GLI3

被引:35
作者
Furniss, Dominic
Critchley, Paul
Giele, Henk
Wilkie, Andrew O. M. [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England
[2] John Radcliffe Hosp, Oxford Radcliffe Hosp NHS Trust, Dept Plast & Reconstruct Surg, West Wing, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
SALL1; GLI3; nonsense-mediated decay; mutations; pathophysiology; pyrosequencing;
D O I
10.1002/ajmg.a.32097
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mutations in SALLI and GLI3 are responsible for human limb malformation syndromes. The molecular pathophysiology of these mutations is incompletely understood, and many conclusions have been drawn from studies performed in the mouse. We identified truncating mutations in SALLI and GLI3 in patients with limb malformation and studied the contribution of nonsense-mediated decay (NMD) to the expression of mutant mRNA in patient-derived fibroblasts. Quantification of the relative proportions of mutant and wild-type alleles was performed by pyrosequencing. In SALL1, a mutant allele causing Townes-Brocks syndrome was unexpectedly resistant to NMD, whereas a different mutation causing a much milder phenotype was susceptible to NMD. In GLI3, all three mutant alleles tested were susceptible to NMD. This work provides novel insights into the molecular pathophysiology of SALLI and GLI3 mutations, extends the phenotypic spectrum of SALL1 mutations, and provides an example of a human mutation which does not follow the usual accepted positional rules governing mammalian NMD. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:3150 / 3160
页数:11
相关论文
共 28 条
[11]   Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes:: Robust phenotype prediction from the type and position of GLI3 mutations [J].
Johnston, JJ ;
Olivos-Glander, I ;
Killoran, C ;
Elson, E ;
Turner, JT ;
Peters, KF ;
Abbott, MH ;
Aughton, DJ ;
Aylsworth, AS ;
Bamshad, MJ ;
Booth, C ;
Curry, CJ ;
David, A ;
Dinulos, MB ;
Flannery, DB ;
Fox, MA ;
Graham, JM ;
Grange, DK ;
Guttmacher, AE ;
Hannibal, MC ;
Henn, W ;
Hennekam, RCM ;
Holmes, LB ;
Hoyme, HE ;
Leppig, KA ;
Lin, AE ;
MacLeod, P ;
Manchester, DK ;
Marcelis, C ;
Mazzanti, L ;
McCann, E ;
McDonald, MT ;
Mendelsohn, NJ ;
Moeschler, JB ;
Moghaddam, B ;
Neri, G ;
Newbury-Ecob, R ;
Pagon, RA ;
Phillips, JA ;
Sadler, LS ;
Stoler, JM ;
Tilstra, D ;
Vockley, CMW ;
Zackai, EH ;
Zadeh, TM ;
Brueton, L ;
Black, GCM ;
Biesecker, LG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) :609-622
[12]   GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome [J].
Kang, S ;
Graham, JM ;
Olney, AH ;
Biesecker, LG .
NATURE GENETICS, 1997, 15 (03) :266-268
[13]   Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease [J].
Khajavi, Mehrdad ;
Inoue, Ken ;
Lupski, James R. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2006, 14 (10) :1074-1081
[14]   Expression of a truncated Sall1 transcriptional repressor is responsible for Townes-Brocks syndrome birth defects [J].
Kiefer, SM ;
Ohlemiller, KK ;
Yang, J ;
McDill, BW ;
Kohlhase, J ;
Rauchman, M .
HUMAN MOLECULAR GENETICS, 2003, 12 (17) :2221-2227
[15]   Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome [J].
Kohlhase, J ;
Wischermann, A ;
Reichenbach, H ;
Froster, U ;
Engel, W .
NATURE GENETICS, 1998, 18 (01) :81-83
[16]   Genetic variation analyses by Pyrosequencing [J].
Langaee, T ;
Ronaghi, M .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 573 (1-2) :96-102
[17]   When the message goes awry: Disease-producing mutations that influence mRNA content and performance [J].
Mendell, JT ;
Dietz, HC .
CELL, 2001, 107 (04) :411-414
[18]  
Nishinakamura R, 2001, DEVELOPMENT, V128, P3105
[19]   The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons [J].
Perrin-Vidoz, L ;
Sinilnikova, OM ;
Stoppa-Lyonnet, D ;
Lenoir, GM ;
Mazoyer, S .
HUMAN MOLECULAR GENETICS, 2002, 11 (23) :2805-2814
[20]   The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-A/B; No phenotype prediction from the position of GLI3 mutations [J].
Radhakrishna, U ;
Bornholdt, D ;
Scott, HS ;
Patel, UC ;
Rossier, C ;
Engel, H ;
Bottani, A ;
Chandal, D ;
Blouin, JL ;
Solanki, JV ;
Grzeschik, KH ;
Antonarakis, SE .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :645-655